## References

1. Mandell G, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier, 2010.
2. Curtis C, Ogbogu PU. Evaluation and differential diagnosis of persistent marked eosinophilia. Immunol Allergy Clin North Am 2015;35:387-402.
3. Falchi L, Verstovsek S. Eosinophilia in hematologic disorders. Immunol Allergy Clin North Am 2015;35:439-52.
4. Hills AG, Forsham PH, Finch CA. Changes in circulating leukocytes induced by the administration of pituitary adrenocorticotrophic hormone in man. Blood 1948;3:755-68.
5. Spry C. Eosinophilia in Addison's disease. Yale J Biol Med 1976;49:411-3.
6. O'Connell EM, Nutman TB. Eosinophilia in infectious diseases. Immunol Allergy Clin North Am 2015;35:493-522.
7. Parasites â€” trichinellosis (also known as trichinosis). Atlanta: Centers for Disease Control and Prevention, 2012 (https://www.cdc.gov/parasites/trichinellosis/disease.html).
8. Knopp S, Steinmann P, Keiser J, Utzinger J. Nematode infections: soil-transmitted helminths and trichinella. Infect Dis Clin North Am 2012;26:341-58.
9. Kuruvilla M, Khan DA. Eosinophilic drug allergy. Clin Rev Allergy Immunol 2016;50:228-39.
10. Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010;146:1373-9.
11. Ebell MH, Call M, Shinholser J, Gardner J. Does this patient have infectious mononucleosis? The Rational Clinical Examination systematic review. JAMA 2016; 315:1502-9.
12. Dunmire SK, Hogquist KA, Balfour HH. Infectious mononucleosis. Curr Top Microbiol Immunol 2015;390:211-40.
13. Thamcharoen N, Sornprom S, Permpalung N, Hyman CL. False positivity of monospot test in an immunocompetent elderly woman with acute cytomegalovirus infection. Am J Emerg Med 2015;33(10): 1544.e1-2.
14. Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med 2007;120(10):911.e1-8.
15. Aouam K, Bel Hadj Ali H, Youssef M, et al. Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests. Epilepsia 2008;49:1630-3.
16. Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-4.
17. Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci 2017;18:E1243.
18. Leong HN, Tuke PW, Tedder RS, et al. The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol 2007;79:45-51.
19. Morissette G, Flamand L. Herpesviruses and chromosomal integration. J Virol 2010;84:12100-9.
20. Tanaka-Taya K, Sashihara J, Kurahashi H, et al. Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol 2004;73: 465-73.
21. Fox JD, Ward P, Briggs M, Irving W, Stammers TG, Tedder RS. Production of IgM antibody to HHV-6 in reactivation and primary infection. Epidemiol Infect 1990;104:289-96.
22. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. J Am Acad Dermatol 2013;68(5):709.e1-9.